MEFV innate immunity regulator, pyrin
Last updated 3 Apr 2025
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The MEFV gene provides instructions for making a protein called pyrin (also known as marenostrin). Although pyrin's function is not fully understood, it likely assists in keeping the inflammation process under control. Inflammation occurs when the immune system sends signaling molecules and white blood cells to a site of injury or disease to fight microbial invaders and facilitate tissue repair. When this has been accomplished, the body stops the inflammatory response to prevent damage to its own cells and tissues.
Video picks for GenesVideo library
Normal function
The MEFV gene provides instructions for making a protein called pyrin (also known as marenostrin). Although pyrin's function is not fully understood, it likely assists in keeping the inflammation process under control. Inflammation occurs when the immune system sends signaling molecules and white blood cells to a site of injury or disease to fight microbial invaders and facilitate tissue repair. When this has been accomplished, the body stops the inflammatory response to prevent damage to its own cells and tissues.
Pyrin is produced in certain white blood cells (neutrophils, eosinophils, and monocytes) that play a role in inflammation and in fighting infection. Pyrin may direct the migration of white blood cells to sites of inflammation and stop or slow the inflammatory response when it is no longer needed. Pyrin also interacts with other molecules to assemble themselves into structures called inflammasomes, which are involved in the process of inflammation. Research indicates that pyrin helps regulate inflammation by interacting with the cytoskeleton, the structural framework that helps to define the shape, size, and movement of a cell.
Conditions referring to this gene or chromosome
Other names
FMF
marenostrin
Mediterranean fever
MEF
MEFV_HUMAN
MRST
pyrin
TRIM20
Patient picks for Genes

Health news
Influencers are promoting dangerous peptides on social media – and regulators are struggling to keep up
Once confined to niche bodybuilding forums and hardcore gyms, unproven injectable peptides are now being openly marketed online to the average gym-goer by social media influencers – and regulators struggling to keep up. Across Instagram, TikTok or YouTube, unapproved and harmful peptide products are being promoted as shortcuts to fat loss, anti-ageing, health and recovery and muscle growth. Peptides actually occur naturally in our body. They regulate a variety of important functions, including metabolism, appetite, hormone production and tissue repair. Synthetic versions of peptides are also used in some medicines, which are legitimate and have been clinically proven. These include GLP-1s (which are used for weight loss and managing diabetes) and insulin. But a booming, parallel “grey market” now exists online for unapproved peptide compounds. These products are primarily being sold by so-called wellness brands and in influencer-led storefronts. Many of these products are marketed as cutting-edge solutions for optimising health and body enhancement. The problem is that many of these substances have not undergone full clinical safety evaluation and are not approved for human use. Many have also been found to be contaminated with other harmful ingredients. Unapproved injectable peptides therefore pose serious health risks. Some of the risks they may pose00092-0/abstract) include nausea, vomiting, abdominal pain, gastrointestinal issues, headaches and fatigue or weakness. Immune issues, as well as allergic reactions and infections have also been reported. Moreover, there’s a clear lack of rigorous human safety data. Yet these risks often aren’t disclosed by the people selling them.
by Luke Cox

Allergies, blood and immune system
How to improve your immunity through diet and lifestyle
A strong immune system will help you ward off all sorts of infections. Here we explain how you can boost your immunity by eating the right foods, by looking after your skin, and by keeping your body active.
by Dr Sarah Jarvis

COVID-19
Do you get better COVID-19 immunity from vaccination or infection?
Scores of people have caught COVID-19 over the last few months, due to the spread of the easily transmissible Omicron variant. With more people becoming infected, questions have been raised over whether vaccination or previous infection offers better COVID-19 immunity.
by Lydia Smith

COVID-19
COVID-19: What is herd immunity and will we ever reach it?
As more people are vaccinated against COVID-19, there has been a lot of discussion about whether the UK will ever reach herd immunity. However, with the chance of reinfection higher with the Omicron variant - even among the fully vaccinated - whether this will happen remains to be seen. But what exactly is herd immunity and how does it work?
by Lydia Smith
Related patient information and medicines

Patient information leaflet
The immune system
This leaflet gives a brief overview of the immune system and how it works. A person with a weak immune system might have difficulty fighting off infections. In autoimmune diseases the body is unable to tell what is its own and what is foreign, so it attacks itself. These form what are known as the innate system. The innate immune system The innate.

Patient information leaflet
Pneumonia
It's usually caused by bacterial infections but can also be caused by viral infections, and sometimes fungi. This leaflet explains the types, causes, symptoms, treatment, and prevention of pneumonia. Key points Pneumonia is a lung infection that causes inflammation and fluid in the air sacs, making breathing difficult. Respiratory viruses such as.

Patient information leaflet
Malaria
The most common symptoms are high temperature (fever) and a flu-like illness. The symptoms of malaria can occur up to a year after being bitten in an area in which malaria is present. Prompt treatment for malaria is essential as, without treatment, it can be fatal. This leaflet gives general information about malaria and its treatment. What is.

Patient information leaflet
Chickenpox contact in pregnancy
If you have chickenpox when pregnant, you are likely to make a full recovery. However, serious complications occur in a small number of cases. Most adults in the UK have had chickenpox as a child and are therefore immune to it. However, about 3 in 1,000 pregnant women develop chickenpox. If you have chickenpox when pregnant you are likely to make.

Patient information leaflet
Fibre and fibre supplements
A diet with plenty of fibre: Will help to prevent and treat constipation Constipation and ease bowel movements. May help to prevent some bowel conditions such as diverticular disease Diverticula , piles (haemorrhoids) Piles and a painful condition of the back passage (anus), which is called anal fissure Anal fissure. May help you to lose or.

Patient information leaflet
Tension headache
Your heada... Your headache is worse when you sit or stand. Your headaches are not like anything you have ever experienced before. You have unexplained nausea or vomiting (sickness) Nausea and vomiting with the headache. You have low immunity - for example, if you have HIV HIV and AIDs , or are on oral steroid medication or medicines which.
Further reading and references
- MEFV innate immunity regulator, pyrin; MedlinePlus, National Library of Medicine.
- Aksentijevich I, Torosyan Y, Samuels J, Centola M, Pras E, Chae JJ, Oddoux C, Wood G, Azzaro MP, Palumbo G, Giustolisi R, Pras M, Ostrer H, Kastner DL. Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. Am J Hum Genet. 1999 Apr;64(4):949-62. doi: 10.1086/302327.
- Bakkaloglu A. Familial Mediterranean fever. Pediatr Nephrol. 2003 Sep;18(9):853-9. doi: 10.1007/s00467-003-1185-2. Epub 2003 Jun 27.
- Chae JJ, Wood G, Masters SL, Richard K, Park G, Smith BJ, Kastner DL. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):9982-7. doi: 10.1073/pnas.0602081103. Epub 2006 Jun 19.
- Delibas A, Oner A, Balci B, Demircin G, Bulbul M, Bek K, Erdogan O, Baysun S, Yilmaz E. Genetic risk factors of amyloidogenesis in familial Mediterranean fever. Am J Nephrol. 2005 Sep-Oct;25(5):434-40. doi: 10.1159/000087824. Epub 2005 Aug 23.
- Gershoni-Baruch R, Brik R, Zacks N, Shinawi M, Lidar M, Livneh A. The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum. 2003 Apr;48(4):1149-55. doi: 10.1002/art.10944.
- Mansfield E, Chae JJ, Komarow HD, Brotz TM, Frucht DM, Aksentijevich I, Kastner DL. The familial Mediterranean fever protein, pyrin, associates with microtubules and colocalizes with actin filaments. Blood. 2001 Aug 1;98(3):851-9. doi: 10.1182/blood.v98.3.851.
- Medlej-Hashim M, Delague V, Chouery E, Salem N, Rawashdeh M, Lefranc G, Loiselet J, Megarbane A. Amyloidosis in familial Mediterranean fever patients: correlation with MEFV genotype and SAA1 and MICA polymorphisms effects. BMC Med Genet. 2004 Feb 10;5:4. doi: 10.1186/1471-2350-5-4.
- Mikula M, Buller A, Sun W, Strom CM. Prevalence of known mutations in the familial Mediterranean fever gene (MEFV) in various carrier screening populations. Genet Med. 2008 May;10(5):349-52. doi: 10.1097/GIM.0b013e3181723cc8.
- Milhavet F, Cuisset L, Hoffman HM, Slim R, El-Shanti H, Aksentijevich I, Lesage S, Waterham H, Wise C, Sarrauste de Menthiere C, Touitou I. The infevers autoinflammatory mutation online registry: update with new genes and functions. Hum Mutat. 2008 Jun;29(6):803-8. doi: 10.1002/humu.20720.
- Notarnicola C, Didelot MN, Kone-Paut I, Seguret F, Demaille J, Touitou I. Reduced MEFV messenger RNA expression in patients with familial Mediterranean fever. Arthritis Rheum. 2002 Oct;46(10):2785-93. doi: 10.1002/art.10575.
- Papin S, Cuenin S, Agostini L, Martinon F, Werner S, Beer HD, Grutter C, Grutter M, Tschopp J. The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing. Cell Death Differ. 2007 Aug;14(8):1457-66. doi: 10.1038/sj.cdd.4402142. Epub 2007 Apr 13.
- Rabinovitch E, Harats D, Yaron P, Luvish T, Lidar M, Kedem R, Shaish A, Ben-Dov I, Livneh A. Familial Mediterranean fever gene and protection against asthma. Ann Allergy Asthma Immunol. 2007 Dec;99(6):517-21. doi: 10.1016/S1081-1206(10)60380-8.
- Ross JJ. Goats, germs, and fever: Are the pyrin mutations responsible for familial Mediterranean fever protective against Brucellosis? Med Hypotheses. 2007;68(3):499-501. doi: 10.1016/j.mehy.2006.07.027. Epub 2006 Sep 26.
- Stoffman N, Magal N, Shohat T, Lotan R, Koman S, Oron A, Danon Y, Halpern GJ, Lifshitz Y, Shohat M. Higher than expected carrier rates for familial Mediterranean fever in various Jewish ethnic groups. Eur J Hum Genet. 2000 Apr;8(4):307-10. doi: 10.1038/sj.ejhg.5200446.
- Telatar M, Grody WW. Molecular genetic testing for familial Mediterranean fever. Mol Genet Metab. 2000 Sep-Oct;71(1-2):256-60. doi: 10.1006/mgme.2000.3047. No abstract available.
- Yepiskoposyan L, Harutyunyan A. Population genetics of familial Mediterranean fever: a review. Eur J Hum Genet. 2007 Sep;15(9):911-6. doi: 10.1038/sj.ejhg.5201869. Epub 2007 Jun 13.
- Yu JW, Fernandes-Alnemri T, Datta P, Wu J, Juliana C, Solorzano L, McCormick M, Zhang Z, Alnemri ES. Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants. Mol Cell. 2007 Oct 26;28(2):214-27. doi: 10.1016/j.molcel.2007.08.029.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

